IMANIS LIFE SCIENCES, LLC

Rochester, MN · Founded 2012 · Biotech · Private

NIS reporter gene variants optimized for molecular imaging of cells, genes, and viruses in living organisms using radiotracers

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · imanislife.com

Sector: Biotech
Headquarters: Rochester, MN
Founded: 2012
Latest Form D: $1M, Mar 2014
Total capital: $2.8M

Federal grants: $1.7M; 3 awards · 2015–2018; Rank in peer group#128 of 326
Private capital raised: $1M; 1 Form D · last Mar 2014; 151 months since last filing
Federal contracts: $101K; 1 award · Health and Human S; Rank in Biotech#327 of 4373
Granted patents: None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

Latest events

Mar 2018Federal grantHealth and Human S · Phase II · Phase 2: NIS proteins with altered anion specificity$734K
May 2017Federal grantHealth and Human S · Phase II · Phase 2: NIS proteins with altered anion specificity$732K
May 2015Federal grantHealth and Human S · Phase I · Longitudinal In Vivo Imaging of NIS Expressing Stem Cells$203K
Aug 2014Federal contractHealth and Human S · Ambis # 1689648 Custom Production Of A Panel Of Lentivectors For In Vitro Cell Culture Experiments, Lv-sffv-hnis-gfp. For In Vivo Imaging Study In Nhp Lv-sffv-rhnis; Custom Design Of New Generation Vectors For In Vivo Imaging Studies With New Generation.$101K
Mar 2014Private capital raisedForm D · SEC · 1st filing$1M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 326 peers

Line = median

Biotech · Molecule

Federal grants#128 · top 39%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings

Dr. Stephen RussellExecutive Officer, Director, PromoterNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

ChemocentryxSimilar federal contract value in Biotech · $107K in contracts
SeromYx Systems, Inc.Similar federal contract value in Biotech · $107K in contracts
Xona Microfluidics, Inc.Similar federal contract value in Biotech · $104K in contracts
CARRYGENES BIOENGINEERING, LLCSimilar federal contract value in Biotech · $101K in contracts
EXEMPLAR GENETICS, LLCSimilar federal contract value in Biotech · $101K in contracts
SYNZYME TECHNOLOGIES LLCSimilar federal contract value in Biotech · $100K in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.